Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron and dose-ranging palonosetron for prevention of postoperative nausea and vomiting after eye enucleation with orbital hydroxyapatite implantation
ChiCTR-IPR-15005852Phase 4Recruiting
- Sponsor
- Eye, Ear, Nose, and Throat Hospital
- Start
- Jan 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of granisetron, palonosetron, droperidol and dexamethasone in postoperative nausea and vomiting (PONV) (6 arms), sponsored by Eye, Ear, Nose, and Throat Hospital. Primary endpoints: Severity of nausea and vomiting at different time points, Complete response and 1 more. Started Jan 2015; status: recruiting.
02
Drugs
granisetronpalonosetrondroperidoldexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR-IPR-15005852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005852.